Literature DB >> 21035207

Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction.

Micha T Maeder1, David M Kaye.   

Abstract

BACKGROUND: In contrast to patients with heart failure (HF) with reduced left ventricular ejection fraction (LVEF; HFREF) the prognostic role of heart rate (HR) and blood pressure (BP) in patients with HF and preserved LVEF (HFPEF) is not well known. The aim of this study was to characterize the relationship between HR and BP and outcomes in HFPEF and to compare it to HFREF.
METHODS: The association between HR and BP and outcomes (median follow-up: 38 months) was analyzed in patients with HFREF (LVEF ≤ 45%; n=6792) and HFPEF (LVEF > 45%; n=988) from the Digitalis Investigator Group trial.
RESULTS: Mortality (35% vs. 23%) and HF hospitalization rates (31% vs. 20%; p<0.001 for both) were higher in HFREF compared to HFPEF. In HFREF, higher HR and lower systolic and diastolic BP quartiles were associated with higher mortality and HF hospitalization rates. By contrast, there was no significant association between HR and BP respectively and mortality in HFPEF, and there was no significant association between systolic BP and hospitalization risk in HFPEF either. However, HF hospitalization rates were significantly related to increasing HR and decreasing diastolic BP quartile respectively (4.9, 6.8, 6.8, and 10.5 and 5.5, 8.1, 6.0, and 10.1 respectively events per 1000 person-years) in HFPEF. In HFPEF, there was also evidence of a significant J-shaped relationship between pulse pressure and mortality.
CONCLUSIONS: The prognostic value of HR and BP differed substantially between HFREF and HFPEF. These data may provide a foundation for the design of novel interventions in HFPEF patients. Crown
Copyright © 2010. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21035207     DOI: 10.1016/j.ijcard.2010.10.007

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  13 in total

1.  Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial.

Authors:  Marco R Di Tullio; Min Qian; John L P Thompson; Arthur J Labovitz; Douglas L Mann; Ralph L Sacco; Patrick M Pullicino; Ronald S Freudenberger; John R Teerlink; Susan Graham; Gregory Y H Lip; Bruce Levin; J P Mohr; Richard Buchsbaum; Conrado J Estol; Dirk J Lok; Piotr Ponikowski; Stefan D Anker; Shunichi Homma
Journal:  Stroke       Date:  2016-06-28       Impact factor: 7.914

2.  The Management of Heart Failure with Preserved Ejection Fraction.

Authors:  Andrew Js Coats; Louise G Shewan
Journal:  Card Fail Rev       Date:  2015-04

3.  Heart rate and the risk of adverse outcomes in patients with heart failure with preserved ejection fraction.

Authors:  Wesley T O'Neal; Pratik B Sandesara; Ayman Samman-Tahhan; Heval M Kelli; Muhammad Hammadah; Elsayed Z Soliman
Journal:  Eur J Prev Cardiol       Date:  2017-05-09       Impact factor: 7.804

Review 4.  The Role of Arterial Stiffness and Central Hemodynamics in Heart Failure.

Authors:  Thomas Weber
Journal:  Int J Heart Fail       Date:  2020-09-23

Review 5.  Medication management of chronic heart failure in older adults.

Authors:  Kannayiram Alagiakrishnan; Maciej Banach; Linda G Jones; Ali Ahmed; Wilbert S Aronow
Journal:  Drugs Aging       Date:  2013-10       Impact factor: 3.923

6.  A multilayered scaffold of a chitosan and gelatin hydrogel supported by a PCL core for cardiac tissue engineering.

Authors:  Seokwon Pok; Jackson D Myers; Sundararajan V Madihally; Jeffrey G Jacot
Journal:  Acta Biomater       Date:  2012-11-02       Impact factor: 8.947

7.  Long-term outcome of hypertensive patients with heart failure with mid-range ejection fraction: The significance of blood pressure control.

Authors:  Maria E Marketou; Spyros Maragkoudakis; Kostantinos Fragiadakis; John Konstantinou; Alexandros Patrianakos; Spyridon Kassotakis; Ioannis Anastasiou; Afroditi Alevizaki; Artemis Kostaki; Gregory Chlouverakis; Panos E Vardas; Fragiskos I Parthenakis
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-07-08       Impact factor: 3.738

Review 8.  Diagnosis and management of heart failure with preserved ejection fraction: 10 key lessons.

Authors:  A Afşin Oktay; Sanjiv J Shah
Journal:  Curr Cardiol Rev       Date:  2015

Review 9.  Advances in the management of heart failure: the role of ivabradine.

Authors:  Ursula Müller-Werdan; Georg Stöckl; Karl Werdan
Journal:  Vasc Health Risk Manag       Date:  2016-11-17

10.  Magnitude of and Prognostic Factors Associated With 1-Year Mortality After Hospital Discharge for Acute Decompensated Heart Failure Based on Ejection Fraction Findings.

Authors:  Andrew H Coles; Mayra Tisminetzky; Jorge Yarzebski; Darleen Lessard; Joel M Gore; Chad E Darling; Robert J Goldberg
Journal:  J Am Heart Assoc       Date:  2015-12-23       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.